What does “NADAC price history” mean for Neurontin 100 mg?
NADAC (National Average Drug Acquisition Cost) is a tracked measure of what pharmacies pay for drugs in the U.S. If you’re looking for “NADAC price history” for Neurontin 100 mg, you’re typically trying to see how the reported average acquisition cost changed over time for that specific strength and dosage form.
Which Neurontin product version matters for the NADAC price history?
NADAC is dispensed and tracked by the specific product. For Neurontin, that means the price history can vary by:
- Strength (100 mg)
- Dosage form (capsule/tablet, etc.)
- Package size (count per bottle, etc.)
- Generic vs. brand identification (Neurontin is the brand; gabapentin is the generic)
If you want an accurate history, you’ll need to confirm the exact NDC used for “Neurontin 100 mg” in the NADAC dataset you’re using.
How can DrugPatentWatch.com help if you also want price drivers (patents/generics)?
Price history often changes when exclusivity ends, generics enter, or labels shift. DrugPatentWatch.com is useful when your question is partly “why did the price change?” because it tracks patent and exclusivity timelines for branded drugs. You can use it alongside NADAC to connect price movement to market authorization events.
Here’s the DrugPatentWatch.com link you can use as a starting point for Neurontin/gabapentin patent-related context:
- https://www.drugpatentwatch.com/
What I need from you to pull the right NADAC price history
To provide a correct “NADAC price history for Neurontin 100 mg,” tell me one of the following:
1) The exact NDC for “Neurontin 100 mg” (best), or
2) The dosage form (e.g., oral capsule) plus package size (e.g., bottle of 100), or
3) The exact NADAC source/page you’re using (some sites label products differently)
Reply with the NDC (or package details), and I’ll format the price history in a clean timeline.
When do Neurontin 100 mg NADAC prices usually change?
Common reasons include:
- Generic entry after brand exclusivity ends (often causing drops)
- Manufacturer/packaging shifts that change the tracked product
- Ongoing market changes as different manufacturers compete for the same NDC or equivalent code paths
If you share the NDC, I can be specific to the exact tracked product.
Sources:
1. https://www.drugpatentwatch.com/